🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and Rare Diseases ── Kidney, liver and gut ── 2026-10-16

Input is PAS-stained biopsy images. Because MEST-C assessment relies on pathologist interpretation, DU-KAN, a dual-branch encoder framework, segments the images with mean Dice 69.58%, then aggregates outputs into case-level MEST-C-related indicators. In 40 exploratory cases, full agreement was 65.00% and sensitivity for E was 37.50%, so it serves only as an auxiliary reference.
Image abstract — the whole article on one page (click to enlarge)
1 Kidney, liver and gut papers. Lead: DU-KAN: A Dual-Domain Enhanced Deep-Learning Framework for Digital Pathology-Based Oxford MEST-C Assessment in Pediatric IgA Nephropathy

Journals covered and how papers are chosen: see the index

Rare kidney, liver and gastrointestinal diseases: treatment, trials and AI

← Back to this issue